New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
January 23, 2013
10:09 EDTVZ, SRC, MIDD, HMC, ALU, LVS, WLT, KEY, STR, KBH, DHI, D, ANR, UNM, NVS, IBM, COST, NOn The Fly: Analyst Upgrade Summary
Today's noteworthy upgrades include: Alcatel-Lucent (ALU) upgraded to Neutral from Sell at Citigroup... Costco (COST) upgraded to Market Perform from Underperform at Bernstein... D.R. Horton (DHI) upgraded to Market Perform from Underperform at Raymond James... Honda (HMC) upgraded to Outperform from Neutral at Macquarie... IBM (IBM) upgraded to Hold from Sell at Societe Generale... KB Home (KBH) upgraded to Market Perform from Underperform at Raymond James... Middleby (MIDD) upgraded to Outperform from Neutral at RW Baird.. Novartis (NVS) upgraded to Buy from Neutral at Citigroup... Platinum Group (PLG) upgraded to Outperform from Sector Perform at RBC Capital... Questar (STR) upgraded to Buy from Neutral at Citigroup... Spirit Realty (SRC) upgraded to Outperform from Market Perform at Raymond James... Unum Group (UNM) upgraded to Overweight from Equal Weight at Barclays... Verizon (VZ) upgraded to Buy from Hold at Canaccord... KeyCorp (KEY) upgraded to Outperform from Sell at CLSA... Alpha Natural (ANR) upgraded to Buy from Hold at Dahlman Rose... Walter Energy (WLT) upgraded to Buy from Hold at Dahlman Rose... NetSuite (N) upgraded to Buy from Neutral at Lazard Capital... Disney (D) upgraded to Buy from Neutral at B. Riley Caris... Las Vegas Sands (LVS) upgraded to Neutral from Sell at Compass Point.
News For ALU;COST;DHI;HMC;IBM;KBH;MIDD;NVS;STR;SRC;UNM;KEY;VZ;ANR;WLT;N;D;LVS From The Last 14 Days
Check below for free stories on ALU;COST;DHI;HMC;IBM;KBH;MIDD;NVS;STR;SRC;UNM;KEY;VZ;ANR;WLT;N;D;LVS the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | 3 | 4 | 5 | 6 | all recent news | >>
April 9, 2014
09:00 EDTANRAlpha Natural falls 3.3%
Subscribe for More Information
07:09 EDTNVSReckitt Benckiser may be frontrunner for Merck unit, Bloomberg reports
Subscribe for More Information
06:40 EDTWLTWalter Energy downgraded to Sell from Neutral at UBS
Subscribe for More Information
06:40 EDTANRAlpha Natural downgraded to Sell from Neutral at UBS
UBS downgraded Alpha Natural to Sell from Neutral and lowered its price target to $3 from $5 based on lower met coal price forecasts for the sector due to oversupply issues and the latest Q2 benchmark settlement that was lower than expected. The firm expects balance sheets to be stressed and cash burn to accelerate which could result in a 2016 liquidity crisis.
April 8, 2014
10:03 EDTSRCOn The Fly: Analyst Downgrade Summary
Subscribe for More Information
10:00 EDTANRAlpha Natural rises 6.8%
Subscribe for More Information
07:28 EDTIBMSecurity Innovation Network to hold a forum
IT Security Entrepreneurs Forum: ITSEF 2014 is being held in Mountain View, California on April 8-9.
07:22 EDTNVSCaSA-ISPE to hold a conference
21st Annual Lilfe Sciences Technology Conference is being held in Raleigh, North Carolina on April 8.
07:14 EDTVZAT&T wants to force customers in Alabama town to switch to wireless, WSJ reports
Subscribe for More Information
06:41 EDTDU.S. can do little to get gas to Europe in short-term, NY Times says
Although U.S. politicians are talking about exporting gas to Europe to reduce the continent's dependency on Russia, America can export little gas to Europe in the short-term, according to The New York Times. Moreover, a facility being built by Cheniere Energy (LNG) is the only plant that has received all of the regulatory approvals necessary to export natural gas, and in 2017 it will only be able to handle one-sixth of the total amount of gas exported by Russia to Europe, the newspaper added. Companies that are looking to export natural gas from the U.S. other than Cheniere include Sempra (SRE), Dominion (D), BG Group (BRGYY), and Southern Union, which is jointly owned by Energy Transfer Equity (ETE) and Energy Transfer Partners (ETP). Gazprom (OGZPY) is Russia's largest natural gas exporter. Reference Link
05:42 EDTSRCSpirit Realty downgraded to Equal Weight from Overweight at Morgan Stanley
Subscribe for More Information
April 7, 2014
16:01 EDTVZOptions Update; April 7, 2014
Subscribe for More Information
10:10 EDTIBM, NAnalyst sees 'golden' opportunity after software stocks decline
Subscribe for More Information
10:00 EDTDHIOn The Fly: Analyst Downgrade Summary
Subscribe for More Information
09:34 EDTVZActive equity options trading on open
Subscribe for More Information
08:49 EDTNFBR sees 'golden buying opportunity' in enterprise software
FBR Capital says a "'golden buying opportunity" exists in the enterprise software space following the recent sell-off of high-growth names. The firm believes overall software results in Q1 tracked in line to slightly ahead of expectations. It recommends buying Splunk (SPLK), Salesforce.com (CRM), Workday (WDAY), FireEye (FEYE), NetSuite (N) and Palo Alto (PANW) on the recent pullbacks.
07:51 EDTDHID.R. Horton downgraded to Underperform from Market Perform at Raymond James
Raymond James downgraded D.R. Horton to Underperform given exposure to first-time buyers access to mortgage financing and low rankings of communities vs. peers in terms of average school ratings.
07:27 EDTNVSAmerican Association of Cancer Research to hold annual meeting
Subscribe for More Information
07:04 EDTVZCincinnati Bell to sell wireless spectrum licenses to Verizon Wireless
Subscribe for More Information
05:32 EDTNVSNovartis Bexsero vaccine receives FDA Breakthrough Therapy designation
Novartis announced that Bexsero, Meningococcal Group B Vaccine, has received a Breakthrough Therapy designation from the FDA. Bexsero is already approved in Europe, Canada and Australia to help protect against invasive meningococcal disease caused by serogroup B. Novartis plans to file for U.S. licensure of Bexsero as early as Q2; exact timing will depend on guidance from the FDA. This is the fourth Breakthrough Therapy designation for Novartis, underscoring leadership in developing innovative therapies and vaccines. This announcement comes on the heels of a landmark decision from regulators in the UK, where the Joint Committee on Vaccination and Immunisation recommended the inclusion of Bexsero in the country's National Immunisation Programme for routine use in infants from two months of age.
1 | 2 | 3 | 4 | 5 | 6 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use